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Introduction: Controlled prescription opioid use is perceived as a national problem attributed
to all specialties. Our objective was to provide a descriptive analysis of prescriptions written for
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controlled opioids from a database of emergency department (ED) visits prior to the enactment
of the I-STOP law, which requires New York prescribers to consult the Prescription Monitoring
Program (PMP) prior to prescribing Schedule II, III, and IV controlled substances for prescriptions
of greater than five days duration.
Methods: We conducted a retrospective medical record review of patients 21 years of age and
older, who presented to the ED between July 1, 2011 – June 30, 2012 and were given a prescription
for a controlled opioid. Our primary purpose was to characterize each prescription as to the type of
controlled substance, the quantity dispensed, and the duration of the prescription. We also looked
at outliers, those patients who received prescriptions for longer than five days.
Results: A total of 9,502 prescriptions were written for opioids out of a total 63,143 prescriptions
for 69,500 adult patients. Twenty-six (0.27%) of the prescriptions for controlled opioids were written
for greater than five days. Most prescriptions were for five days or less (99.7%, 95% CI [99.6 to
99.8%]).
Conclusion: The vast majority of opioid prescriptions in our ED prior to the I-STOP legislature
were limited to a five-day or less supply. These new regulations were meant to reduce the
ED’s contribution to the rise of opioid related morbidity. This study suggests that the emergency
physicians’ usual prescribing practices were negligibly limited by the new restrictive regulations.
The ED may not be primarily contributing to the increase in opioid-related overdoses and death.
The effect of the I-STOP regulation on future prescribing patterns in the ED remains to be
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Introduction: Controlled prescription opioid use is perceived as a national problem attributed 
to all specialties. Our objective was to provide a descriptive analysis of prescriptions written for 
controlled opioids from a database of emergency department (ED) visits prior to the enactment 
of the I-STOP law, which requires New York prescribers to consult the Prescription Monitoring 
Program (PMP) prior to prescribing Schedule II, III, and IV controlled substances for prescriptions 
of greater than five days duration.
Methods: We conducted a retrospective medical record review of patients 21 years of age and 
older, who presented to the ED between July 1, 2011 – June 30, 2012 and were given a prescription 
for a controlled opioid. Our primary purpose was to characterize each prescription as to the type of 
controlled substance, the quantity dispensed, and the duration of the prescription. We also looked at 
outliers, those patients who received prescriptions for longer than five days.
Results: A total of 9,502 prescriptions were written for opioids out of a total 63,143 prescriptions for 
69,500 adult patients. Twenty-six (0.27%) of the prescriptions for controlled opioids were written for 
greater than five days. Most prescriptions were for five days or less (99.7%, 95% CI [99.6 to 99.8%]).
Conclusion: The vast majority of opioid prescriptions in our ED prior to the I-STOP legislature 
were limited to a five-day or less supply. These new regulations were meant to reduce the ED’s 
contribution to the rise of opioid related morbidity. This study suggests that the emergency 
physicians’ usual prescribing practices were negligibly limited by the new restrictive regulations. The 
ED may not be primarily contributing to the increase in opioid-related overdoses and death. The 
effect of the I-STOP regulation on future prescribing patterns in the ED remains to be determined. 
[West J Emerg Med. 2015;16(1):62–66.]
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Pain is one of the most common chief complaints treated 
in the emergency department (ED), and for many years 
there has been a strong emphasis on addressing adequate 
pain control.1 Despite the increased importance placed on 
providing appropriate analgesia, emergency physicians (EP) 
continue to provide inadequate pain management.2 This 
practice may be related to the clinician’s awareness of the 
significant problems with drug dependence in the United 
States. There is an increase in the abuse of prescription 
drugs, specifically oxycodone and hydrocodone, and it far 
exceeds the increases in abuse of illicit substances, including 
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marijuana, cocaine, and heroin.2
Even with attempts to reduce narcotic abuse and 
addiction, people continue to exhibit violent behaviors 
to obtain narcotics. Violent acts led the New York State 
Legislature to introduce a bill that enhanced the effectiveness 
of New York’s existing Prescription Monitoring Program 
(PMP) with the intention of reducing drug diversion.3 “The 
Internet System for Tracking Over-Prescribing (I-STOP) 
Act” established an online, real-time controlled substance 
reporting system that mandates physicians and pharmacists 
to search for and report certain data at the time a schedule 
II, III, IV, or V controlled substance prescription is issued 
and at the time such substance is dispensed.”4 It took effect 
in August of 2013. In New York, EPs are waived from the 
mandatory consultation of the PMP for prescriptions written 
for five days or less.
There is an association between the maximum prescribed 
daily dose by any physician and opioid overdose-related 
deaths, with higher opioid doses related to an increased risk 
of an opioid overdose death.5-13Although multiple studies 
track the number of prescriptions written by EPs over a period 
of time, our literature search found no articles that examine 
the quantity of opioids prescribed to each individual patient 
during one visit. The duration of pain medications were not 
included in these particular studies.
We designed this descriptive study to assess the 
prescription patterns of EPs for opioids prior to the enactment 
of the New York I-STOP act in a single academic community 
ED on Long Island. Our expectation is that EPs had been 
prescribing no more than five days of controlled opioids even 
before the creation of the new legislation.
METHODS
This was a retrospective chart review to analyze the 
prescriptions for controlled opioids prior to the enactment 
of the I-STOP law. The study was conducted at a suburban 
academic community hospital ED with an annual census of 
approximately 95,000 patients. All patients older than 21 years 
are seen in an adult ED area (69,500). 
The database search included all patients 21 and older 
who received a prescription for a controlled opioid at 
discharge between the dates of July 1, 2011 and June 30, 
2012. We characterized each prescription as to the type of 
controlled opioid, the quantity dispensed, and the length of 
time for the prescription. Medical records with insufficient 
or inconsistent time stamps and/or other entries and patients 
who left prior to formal discharge were excluded. The 
data extracted included the following: hospital account 
number, age, sex, ethnicity, diagnosis, arrival date, time, and 
prescriptions written.
We abstracted the data from the electronic medical 
record (Allscripts ED™ - formerly Healthmatics A4™) 
for patients discharged from the ED with one or more 
prescriptions. This computerized patient charting and 
order entry system enables the collection of standardized 
information for each patient and integrates that information 
into a relational database and also has the advantage 
of generating prescriptions that were included in the 
medical record. The database was queried by SQL Cognos 
Impromptu™ (Cognos), which allows the administrator 
to create reports using criteria filters. Using the inclusion 
criteria, a report was created with Cognos that queried 
all patients seen in the ED who fit the criteria for study 
enrollment. This report was further analyzed by Microsoft 
Excel 2007. This method has been used and described in 
other studies.14-16
The prescriptions analyzed were those written for 
opioids including hydrocodone, morphine, hydromorphone, 
and fentanyl (patches) as seen in Table 1. Tramadol was not 
analyzed, as it only has been considered a controlled substance 
in New York since August 27, 2012. We also excluded a 
cough syrup containing hydrocodone with homatropine in low 
dose (Hycodan®) because it was never prescribed in amounts 
of more than 120mL, which was equivalent to the total 
hydrocodone of 24 pills (a quantity usually of no more than 
five days as traditionally prescribed), and we could find little 
evidence for this significantly contributing to the epidemic of 
prescription drug abuse overdoses or deaths.
We calculated the number of days prescribed by using 
the number of doses prescribed, shortest recommended 
dosing frequency and converting this to the number of 
days the prescription would last (Figure 1). All patient 
charts that had a prescription of more than five days were 
manually reviewed.
RESULTS
A total of 63,143 prescriptions were written between 
July 1, 2011 and June 30, 2012. The demographics are listed 
in Table 2. Of those prescriptions, 9,502 prescriptions were 
written for opioids. We excluded 71 prescriptions from the 
study because they were duplicates of the original prescription 
or lacking information on the prescription to calculate the 
number of days. Of the 9,502 prescriptions written that 
were included in our study, 99.7% already complied with 
the new regulations (95% CI [99.6 to 99.8%]). Twenty-six 
prescriptions (0.27%) were written for greater than five days 
as seen in Figure 2. Some were a result of larger intervals 
between each dose than typically recommended. For example, 






Table 1. Percentage of opioid prescriptions written.
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Opioid All prescription
N 9,502 28,621
Mean age, y (SD) 44.9 (15.2) 44 (16.4)
Male (%) 42.8% 43.2%
White (%) 61.2% 61.5%
Table 2. Demographics of patients receiving opioid versus non-
opioid prescriptions.
Figure 1. Analysis of prescriptions written in the emergency department. 
*The prescriptions that were excluded as listed in the methods section include those written for patients who are less than 21 or have a 
malignancy and chronic inflammatory disease. Patients who also received Hycodan® were also excluded.
Figure 2. Diagnosis of patients receiving opioid prescriptions for 
greater than 5 days (n=26). 
fentanyl usually is packaged in a box of five patches and each 
patch is used for three days at a time. The prescriptions written 
for greater than five days were categorized by diagnosis. 
A breakdown of the 26 outlying prescriptions and related 
diagnoses are provided in Figure 2 with their corresponding 
diagnoses. All written opioid prescriptions were further 
divided by the number of days they were written for, which is 
seen in Figure 3.
Our study found that prescriptions for opioids were 
usually for no more than five days in length and would have 
almost always complied with the new state regulations.
DISCUSSION
I-STOP made New York the first state in the nation to 
mandate that physicians consult a database of a patient’s 
prescription history before prescribing a schedule II, III, or IV 
controlled substance.17 Studies analyzing the impact of PMPs 
have been unanimous in regards to decreasing drug dependence 
and diversion by inhibiting growth in prescription sales for 
pain relievers. This act may further enhance the PMP’s goal; 
however, it can be hindering in an emergency setting. There is 
ongoing concern about EPs undertreating pain and the majority 
of emergency patients suffering from acute injury.
In the ED, pain management continues to be a 
significant complaint requiring practitioner attention as 
seen from the data of this study where approximately one-
sixth of all prescriptions written were for opioid analgesics. 
As seen in numerous studies conducted previously, 
oxycodone continues to be the most commonly prescribed 
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opioid (84%).15,18-20 We were able to illustrate that in a 
large suburban, community ED, most physicians were 
prescribing five days or less worth of prescriptions for 
opioids, with the majority being for three days or less. This 
pattern could be affected by the presence of an electronic 
medical record (EMR) that has prebuilt prescriptions for 
a set number of pills. Even though prescriptions could be 
typed up individually with varying dosing and number of 
pills, it might be more efficient for a physician to select a 
prebuilt prescription.
Of the opioids considered in this study, short-acting 
oxycodone is still the most commonly prescribed opioid 
as well as the most commonly prescribed for greater than 
five days. The small number of patients who received 
more than five days’ worth of opioids had pain from acute 
musculoskeletal injuries, chronic low back pain, herniated 
disc, and diabetic neuropathy.
Giving ED physicians the privilege of providing opioid 
pain relievers without referring to the PMP permits them to 
function effectively in their environment. Our study shows 
that the EP already displays independent responsibility in 
opioid prescribing patterns. The PMP in theory may add little 
to reduce the amount of drug overdoses in the ED setting.
Prior to enactment of this legislation, EPs had not been 
giving prescriptions of opioids that were excessive and therefore 
not likely to be contributing to the rise of opioid overdoses 
and deaths in the community. Further regulations requiring 
the additional step of consulting a database before prescribing 
controlled opioids may have the potential to inhibit opioid 
prescriptions for acute pain and promulgate oligoanalgesia.
LIMITATIONS
Our study has several limitations. It was a retrospective 
study and has all the limitation therein. It was completed 
at a single suburban academic community hospital ED 
and therefore might not represent other communities or 
institutions. It cannot determine if the patient is “doctor-
shopping” and visiting other EDs, doctors’ offices, or even 
the same ED but on subsequent days or weeks. We focused 
on the duration of opioid prescriptions written rather than the 
maximum concentration of the opioid all together or total per 
day. There is increased risk of overdose in patients receiving 
medically prescribed opioids at higher doses.5-13
Patients can still “doctor-shop,” and if an EP does not 
have a clinical suspicion for substance abuse, the small 
amounts of opioids given can supply an addiction from 
multiple sources. Furthermore, a patient’s inability to obtain 
a sufficient quantity of prescription opioids may lead them to 
solicit street drugs that have unregulated compositions adding 
to potentially worse adverse outcomes.
The study did not provide any data on the type of 
pain or response to initial treatment. It was not designed 
to determine whether pain was adequately treated. The 
results could be influenced by variations in individual 
provider practice, and the study did not control for the effect 
of clustering by individual providers. Providers in this 
department see patients on a next patient basis and do not 
choose the next patient to be seen, thus minimizing this type 
of selection bias. 
Whether the implementation of this regulation will change 
the prescribing practices of physicians is not known and 
would be an interesting question to pursue.
CONCLUSION
The duration of opioids prescribed from one ED visit 
in this suburban, community Long Island ED prior to the 
I-STOP legislature was largely limited to five days or less. 
This suggests that EPs had been largely abiding with the 
spirit of the new bill prior to its drafting. Although the PMP 
might assist with abuse and dependency of opioids in this 
community, it remains unknown whether this will impact 
optimal prescribing practices for pain.
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Figure 3. Breadkdown of opioid prescriptions into the number of 
days they were written for. 
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